FINWIRES · TerminalLIVE
FINWIRES

Enduro Metals Upsizes a Private Placement of Share Units to $7.8 Million

作者

-- Enduro Metals (ENDR.V) on Thursday said it is upsizing a "best efforts" private placement to $7.8 million from $5 million.

The offering will now consist of the sale of 9.4-million non-flow-through units (NFT units) priced at $0.16 each and made up of a share and one half of a three-year warrant to buy a share for $0.24.

It will also place up to 28.6-million charity flow-through units for $0.22 each and made up of a tax-advantaged share and one half of a warrant with the same terms.

The company will concurrently place up to 6.6-million NFT units at $0.16 apiece for up to $1.1 million on a private placement basis "pursuant to other applicable exemptions from the prospectus requirements under Canadian securities laws".

Proceeds from the sale of NFT units and the concurrent private placement will be used for exploration and development at its mineral projects and for working capital and general corporate needs.

Shares of the company were last seen down $0.01 at $0.165 on the TSX Venture Exchange.

Price: $0.17, Change: $-0.01, Percent Change: -5.71%

相關文章

Research

國民銀行維持對Capstone的「優於大盤」評級,但將目標價從15加元下調至14加元,理由是「目標價小幅下調是考慮到硫酸成本壓力」。

Price: $11.22, Change: $+0.38, Percent Change: +3.51%

$CS.TO
Research

研究快訊:CFRA維持對默克公司股票的買入評級,此前該公司發布了第一季財報。

獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:我們維持目標價135美元,相當於2027年每股盈餘預期值的13.4倍,低於默克公司過去10年的平均預期本益比。我們維持2026年每股收益預期5.14美元,2027年每股收益預期10.06美元。默克公司公佈了2026年第一季穩健的業績,其營收成長強勁,產品線和產品組合轉型也取得了顯著進展。由於腫瘤和動物保健部門的持續強勁表現,以及新產品上市帶來的貢獻不斷增長,總營收達163億美元(年增5%)。該公司正積極執行一項成功的策略,透過內部和外部研發,實現其成長動力來源的多元化,使其不再僅依賴旗艦藥物 KEYTRUDA。我們認為,預計第二季完成的 Terns 收購案,將憑藉其用於治療慢性粒細胞白血病的 TERN-701 進一步增強 MRK 的血液學產品線,這也體現了該公司在戰略轉型過程中持續推進的外部創新舉措。

$MRK
Australia

Leerink Partners 將 Labcorp 的目標價從 347 美元下調至 340 美元。

根據FactSet調查的分析師報告,Labcorp (LH) 的平均評級為“增持”,平均目標價為311.35美元。 (報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們:https://www..com/contact-us)Price: $257.19, Change: $+0.05, Percent Change: +0.02%

$LH